It is a research & development private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 | Mumbai, Maharashtra, India | Struck OffMerkaba Genomic Technologies Private Limited, a struck off private limited company, was established on 24 March 2005 in Mumbai, Maharashtra, India. Engaging in science research within the research & development sector, it holds CIN: U73100MH2005PTC152174. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Its leadership includes Suniel Hiroo Bharwani (Nominee Director), Christina Suniel Bharwani (Director). Past directors included Suniel Hiroo Bharwani, Haresh Gangadhar Tolani, Pradeep Narainsingh Thakur. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at No 1307 Dalmal Towersb-Wing Free Press Journal Marg Nariman Point Mumbai, Mumbai, Maharashtra, 400021.
U73100MH2005PTC152174
152174
24 March 2005
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Merkaba Genomic Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suniel Hiroo Bharwani | Nominee Director | 24 Mar 2005 | Current |
| Christina Suniel Bharwani | Director | 16 Jun 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Oct 2013 | Past |
| Pramod Abcsdd | Director | 06 Feb 2014 | Past |
| Pramod Abcsdd | Director | 06 Jun 2017 | Past |
| Pramod Abcsdd | Director | 16 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Merkaba Genomic Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Merkaba Genomic Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Merkaba Genomic Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Merkaba Genomic Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merkaba Genomic Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Merkaba Genomic Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was documented.
Progress on Christina Suniel Bharwani was appointed as a Director was appointed as a Director on 16 Jun 2014 & has been associated with this company since 11 years 5 months . was documented.
Merkaba Genomic Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai. was recorded as a recent event.
The activity Suniel Hiroo Bharwani was appointed as a Nominee Director was appointed as a Nominee Director on 24 Mar 2005 & has been associated with this company since 20 years 8 months . was completed.
Merkaba Genomic Technologies Private Limited was registered on 24 Mar 2005 with Roc Mumbai & aged 20 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Merkaba Genomic Technologies Private Limited is U73100MH2005PTC152174.
Merkaba Genomic Technologies Private Limited is headquartered at No 1307 Dalmal Towersb-Wing Free Press Journal Marg Nariman Point Mumbai, Mumbai, Maharashtra, 400021.
Merkaba Genomic Technologies Private Limited was incorporated on 24 March 2005.
The current directors of Merkaba Genomic Technologies Private Limited are
The primary industry of Merkaba Genomic Technologies Private Limited is Research & Development.
Merkaba Genomic Technologies Private Limited is unlisted.
The authorized capital of Merkaba Genomic Technologies Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX